Companion Animal Diagnostic Market Size to Reach $3.1 Billion by 2026 – Reported Times

Global Companion Animal Diagnostic Market By Technology (Clinical Biochemistry, Molecular Diagnostics, Immunodiagnostics, Urinalysis, Hematology, and Other), By Animal Type (Dogs, Cats, Horses, and Others), By End-User (Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities), By Application (Bacteriology, Parasitology, Virology, Clinical Pathology, Others); By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2016-2026

The Global Companion Animal Diagnostic Market is estimated to grow at a CAGR of 9.08% during the forecast period 2019-2026. As per the analysis, the global Companion Animal Diagnostic market was valued $1.69 billion in the year 2019 and estimated to reach $3.1 billion by the end of the year 2026. The global market growth is driven by increased adoption of companion animals globally, growth in number of chronic diseases among animals and increasing demand of efficient diagnostics for pet animals.

GET FREE SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC63

Diagnostics tests help in early detection, prevention and control of animal diseases. Increasing demand for fully automated and semi-automated diagnostic tests techniques further support the demand of companion animal diagnostics, which result in increased productivity and help to handle the large volumes of samples. Increasing demand of Point of Care Diagnostics (POCD) will additionally boost the growth of the companion animal diagnostics market. In the market study, it was analyzed that market players are hugely investing in research and development of POCD equipment.

Market Insights

Increasing adoption of pet animals majorly driving the market growth

Growing adoption of companion animals, especially in developed countries, to cope up with emotional disorders and loneliness, or for support, amusement for kids, and sometimes security, are some of the key factors driving the market growth. Moreover, increasing focus of pet-owners towards preventive healthcare, regular health checkup, and increasing expenditure on companion animal healthcare to protect them from different infectious and other diseases such as zoonotic diseases is propelling the market growth. Moreover, the increasing demand for rapid tests and portable instruments for point-of-care services and the use of sophisticated technologies like machine learning is presumed to offer potential growth opportunities for market players in the forthcoming years.

Increasing pet care cost restraint the market growth

The pet care cost is increasing due to the increasing adoption of companion animals. The initial cost of adoption and the whole expenses of the pet owner during the year is high, which is restricting the growth of the market.

Segmentation Overview of the Global Companion Animal Diagnostic Market

The Global Companion Animal Diagnostic Market is segmented on the basis of Technology, Animal Type, End-User and Application. These market segments are further categorized into sub-segments to study the market in detail.

On the basis of Technology Segment, the Global Companion Animal Diagnostic Market is Sub-Segmented into:

On the basis of Animal Type Segment, the Global Companion Animal Diagnostic Market is Sub-Segmented into:

On the basis of End-User Segment, the Global Companion Animal Diagnostic Market is Sub-Segmented into:

On the basis of Application Segment, the Global Companion Animal Diagnostic Market is Sub-Segmented into:

Global Companion Animal Diagnostic Market: Regional Insights

Geographically, the global Companion Animal Diagnostic market is segregated into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is estimated to register the largest revenue share in the target market, owing to higher adoption of companion animals in nations such as the US and Canada in the region, high pervasiveness of chronic diseases, increasing initiative by the government, well-established veterinary healthcare infrastructure. Additionally, North America has strong existence of prominent companies involved in companion R&D of innovative therapeutics and animal diagnostics. Higher spending on pet healthcare is a major factor growth driving factor.

Competitive Landscape

The companies that hold the major share of global Companion Animal Diagnostic market are Scil Animal Care Company GmbH Bionote Inc., Skyla Mindray Medical International Limited, Randox Laboratories, Ltd., IDvet, Fujifilm Holdings Corporation, INDICAL Bioscience GmbH Corporation, Biomrieux SA, Neogen, Virbac, Thermo Fisher Scientific Inc., Heska Corporation IDEXX Laboratories, Inc., Zoetis Inc., Abnova Corporation, Guardant Health, Inc., Illumina Inc. QIAGEN N.V., and other prominent players.

Request for[emailprotected] https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC63

Buy this premium research[emailprotected]https://reportocean.com/industry-verticals/details?report_id=BWC63&pub_code=RO-017&keyword=

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Report OceanName: Pragya NiranjanEmail:[emailprotected]Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 UNITED STATESTel: +1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com/Blog:https://reportoceanblog.com/Business-news:http://thesmartbusinessnews.com/

Visit link:
Companion Animal Diagnostic Market Size to Reach $3.1 Billion by 2026 - Reported Times

Want To Get Away? These Astronauts Talk About Life Off Earth, Dealing With Isolation and Facing Fears – WMFE

Scott Kelly on the International Space Station. Photo: NASA

Since our podcast and radio show Are We There Yet? is celebrating its 4th birthday and many of us are quarantined at home with lots of free time our host Brendan Byrne is sharing his favorite conversations with astronauts.

Listen back to his picks on this binge-able list and be sure to subscribe to the podcast, or listen in every Tuesday at 6:30 p.m. ET on WMFE and WMFV.

Scott Kelly spent almost a year in space as part of an experiment to understand how our bodies function for an extending time in microgravity. He spoke to Byrne about the physiological challenges of life off Earth and the emotion toll isolation took on his mind. Kelly recently wrote an op-ed in the New York Times about his time in isolation and his tips for folks during the coronavirus pandemic.

LISTEN: WMFE | Apple Podcasts | Spotify

Canadian astronaut Chris Hadfield most famously spent his time isolated on the International Space Station filming a music video set to David Bowies Space Oddity. But Hadfields trip wasnt all fun and games there was real danger. He spoke with Byrne about how he deals with fear and the unknown.

LISTEN: WMFE

Nicole Stott is a frequent flier on the podcast. On her first appearance on the show, she talks about the hobby she brought up with her for her long stay on the ISS a set of watercolor paints. She tells Byrne about how her time in space gave her a fresh perspective on life down on Earth.

LISTEN: WMFE | Apple Podcasts | Spotify

Space stinks. Well, it doesnt stink until you come back. NASA astronaut Bruce Melnick talks about the wall of smell that hits you when you return to Earth on the Space Shuttle. Melnick also tells Byrne about the challenges of using the space toilet. Really high-brow stuff, we promise.

LISTEN: WMFE | Apple Podcasts | Spotify

Before making history as part of the first all-female spacewalk, Jessica Meir joined the podcast to talk about her expertise the physiology of animals in extreme environments and how the lessons learned will help get humans back to the moon and on to Mars.

LISTEN: WMFE | Apple Podcasts | Spotify

Do you have a favorite episode? Share it with Brendan Byrne and the rest of the space fans out there shoot us an email at AreWeThereYet@wmfe.org

Go here to read the rest:
Want To Get Away? These Astronauts Talk About Life Off Earth, Dealing With Isolation and Facing Fears - WMFE

They Dont Hide From the Coronavirus, They Confront It – The New York Times

As the world writhes in the grip of Covid-19, the epidemic has revealed something majestic and inspiring: millions of health care workers running to where they are needed, on duty, sometimes risking their own lives. I have never before seen such an extensive, voluntary outpouring of medical help at such a global scale.

Intensive care doctors in Seattle connect with intensive care doctors in Wuhan to gather specific intelligence on what the Chinese have learned: details of diagnostic strategies, the physiology of the disease, approaches to managing lung failure, and more. The three-page, single spaced document, full of lessons, circulates immediately and widely through social media platforms, a gem borne of pure, professional commitment. Facebook starts a COVID-19 USA Physician/APP Group on March 13. It has 57,000 members on March 15, and 105,000 on March 18.

The Journal of the American Medical Association, even while moving its staff home for social distancing, sets new records for speeding helpful scientific studies, peer reviewed, onto the web. Knowledge grows. One JAMA paper is by a group of Wuhan physicians reviewing patterns and outcomes for 1099 patients, showing surprisingly high rates of severe illness in younger adults. Another is an honest account by physicians in Lombardy of both successes and mistakes as they grapple with unprecedented intensive care demands. A list-serve for hospitals started by the Institute for Healthcare Improvement overflows with questions What have you learned about setting up drive-by testing? Has anyone found a new source of masks? and instant answers from institutions and clinicians.

One anesthesiologist in Valhalla, N.Y., types in a suggestion: Instead of giving up when the ventilators are all in use, how about asking groups of students or family members who have become immune to the virus to ventilate patients manually, using Ambu bags, in shifts even for days at a time? Clinicians reply, some critical, some supportive, and all trying to find answers.

And city by city, hospitals mobilize creatively to get ready for the possible deluge: bring in retired staff members, train nurses and doctors in real time, share data on supplies around the region, set up special isolation units and scale up capacity by a factor of 100 or 1000. On Tuesday, Mayor Bill de Blasio of New York asks for retired medical personnel to join the citys Medical Reserve Corps; 24 hours later, 1000 new volunteers have signed up. Northwell Health, a 23-hospital system in New York City, figures out how to add 1,500 beds, if needed, by repurposing space.

Read the original here:
They Dont Hide From the Coronavirus, They Confront It - The New York Times

Fertility wearable to double as COVID-19 temp monitor, as need for population data intensifies – BioWorld Online

Gleaning reliable population-level temperature data routinely has been a key component of the more successful efforts in several Asian countries for containing the emerging, novel coronavirus. But these often have required highly time and labor-intensive coordinated efforts to screen people manually as they access various services such as public transportation and grocery stores.

Remotely monitoring people for the early signs of COVID-19, as well as determining disease progression for infected patients virtually, would offer huge potential advances in better protecting the populace, as well as lessening the burden on swamped health care providers.

Into the gap

Zurich-based startup Ava Science Inc. hopes to step into that gap. The company recently issued a public call for partners and funding to further research the potential usefulness of its fertility wearable, known as Ava Bracelet, during the COVID-19 pandemic.

The effort is not unprecedented; the primary COVID-19 treatment center in Shanghai, the Shanghai Public Health Clinical Center, has been using continuous temperature monitoring in hospitalized patients using wearable technology from Campbell, Calif.-based startup Vivalnk Ltd., which also has a China office. This freed health care staff from routine temperature checks.

Given the current pandemic, we have looked as a company at how we could repurpose our device to help combat the spread of COVID-19, Ava Chief Medical Officer and head of clinical development Maureen Cronin told BioWorld. Cronin was previously the Head of Womens Medical Affairs at Bayer Schering Pharma.

The Ava Bracelet provides the highly accurate temperature readings necessary for this application, as well as other vital sign monitoring. It is already in widespread use throughout the U.S. and Europe and has aided more than 30,000 women in getting pregnant. Ava, which has a U.S. headquarters in San Francisco, is starting to coordinate with various governments, nonprofits, academics and companies to explore the application of its Ava Bracelet for systematic COVID-19 monitoring.

We believe our device, the Ava Bracelet, could be used to detect early symptoms known to be associated with COVID-19 and are seeking funding to test our hypothesis directly, said Cronin. We know that our medical-grade device, worn nightly while the user sleeps, can pick up subtle changes in breathing rate, heart rate, and temperature; the user syncs the device each morning with a smartphone app that shows them how their physiological parameters have changed over the last days, weeks and months.

The nightly log of changes in biophysical data could provide critical insights for first responders and/or people with known or suspected exposure quarantining at home, indicating when they may want to seek medical advice, she continued. Additionally, this data could be shared with health care professionals at time of triaging to demonstrate the trajectory and/or severity of the disease. We believe the Ava bracelet could even serve as a remote surveillance tool in hospital wards, reducing the need for health care professionals to take in-person vitals and thereby minimizing the risk of additional transmission.

In Europe, the device has a CE mark to measure the physiological parameters to facilitate conception and to provide general health and wellness information. In the U.S., where it launched in 2016, FDA approved it as a low-risk class I device for use in conception and physiological changes in subsequent pregnancies. Ava aims to submit to European regulators later this year for a contraception indication.

Remote monitoring priorities

The Ava Bracelet is a wrist worn device that is worn nightly to track breathing rate, pulse rate, skin temperature, heart rate variability, perfusion as well as sleep quality and quantity. Its initial fertility aim was to replace the common fertility practice of monitoring basal body temperature every morning prior to leaving bed to predict when ovulation is most likely to occur.

The most common COVID-19 symptoms are fever, dry cough and shortness of breath, according to the World Health Organization. These occur at a rate of 88%, 68% and 19%, respectively. Ava anticipates that it can detect a fever with both its body temperature and pulse rate monitors, which should both increase, while shortness of breath can be measured as an increased breathing rate. There is obviously no physiological reason why the wearable couldnt be used across genders.

The Ava Bracelet data is analyzed via machine learning to predict a five-day fertile window with 89% accuracy. Its been evaluated in several clinical trials and peer-reviewed manuscripts. The company said that it is currently evaluating data from its users for COVID-19 related trends, but declined to disclose anything further.

The FDA is prioritizing the expansion of the availability and capability of noninvasive remote monitoring devices to facilitate patient monitoring while reducing patient and health care provider contact and exposure to COVID-19 during this pandemic. It released guidance late last week that is designed to enable the smooth repurposing of existing devices and remove potential penalties for repurposing of these devices.

FDA does not intend to object to limited modifications to the indications, claims, functionality, or hardware or software of FDA-cleared non-invasive remote monitoring devices that are used to support patient monitoring during the declared public health emergency, the FDA stated in the new guidance.

Ava declined to name any specific potential partners in its COVID-19 efforts, but did say that it has the capacity to make 50,000 bracelets available shortly with the capacity to further ramp up production. The company has started offering a non-fertility version of the Ava Bracelet for $100 off the standard $249 price to individuals, researchers and medical professionals for physiology tracking.

We have had numerous requests for information and several requests for discussions, said Cronin. The requests have come from current users, potential users, governmental and non-governmental organizations, academics and industries. We are investigating several options as we speak.

We are working towards submitting a grant application for a public-private (academic and industry) grant proposal in Europe by the end of this week, she added. We are a very small organization, but we understand the need to act fast. We are investigating several other proposals in different regions throughout the world and remain open to other proposals.

Read the rest here:
Fertility wearable to double as COVID-19 temp monitor, as need for population data intensifies - BioWorld Online

Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies – P&T…

DUBLIN and TAMPA, Florida, March 24, 2020 /PRNewswire/ -- Avectas, a cell engineering technology business and Vycellix, Inc. an immuno-discovery cell & gene therapy company, today announced that the companies have entered into a collaboration agreement to develop proprietary approaches for cell-based immunotherapeutic products.

The companies will collaborate on the delivery of Vycellix's novel RNA immunomodulator VY-M using Avectas' cell engineering platform, Solupore. The collaboration will address current limitations for cell-based therapies, in particular with respect to the need to accelerate the manufacturing process, reduce the cost of manufacture, and ultimately improve patient outcomes.

"We are delighted to partner with Vycellix and join forces in the development of novel cell-based products," says Michael Maguire, PhD, CEO of Avectas. "We believe Solupore will play a critical role in the manufacture of cell-based therapies and will support a path towards effective patient outcomes."

According to Vycellix's President, Douglas Calder, "Solupore represents a new paradigm for delivery of transgenes, and our initial studies will evaluate Solupore to deliver our new product candidate, VY-M, to T cells and NK cells. We expect to accelerate the expansion-time of T cells and NK cells by decreasing the non-dividing lag time, resulting in much shorter "vein-to-vein" delivery-time to patients." The studies will be conducted at Avectas' Dublin-based facility and at Karolinska Institutet, Stockholm, Sweden.

Both Avectas and Vycellix are collaborative partners within NextGenNK, a newly established competence center for development of next-generation NK cell-based cancer immunotherapies based at Karolinska Institutet, Stockholm, Sweden. It is envisioned that Avectas and Vycellix will further expand their collaboration within the NextGenNK constellation.

"We are excited to see the NextGenNK competence center catalysing interactions among its industrial partners to advance NK cell-based immunotherapies," says Hans-Gustaf Ljunggren, MD PhD, Director of the NextGenNK competence center. "The present collaboration may pave the way for similar collaborations among NextGenNK partners."

In February 2020, Avectas announced that it had entered an agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) based in Toronto, Canada to accelerate the translation of Avectas' non-viral cell engineering platform (Solupore) into the clinic.

About Avectas:Avectas is a cell engineering technology business developing a unique delivery platform to enable the ex-vivo manufacture of our partners' gene-modified cell therapy products, which will retain high in-vivo functionality. Our vision is to be a leading non-viral cell engineering technology provider, integrated into manufacturing processes for multiple autologous and allogeneic therapies, commercialized through development and license agreements. For more information, please visit the Company's website at http://www.avectas.com

About Vycellix:Vycellix, Inc.is a private, immuno-discovery, life science company at the forefront of innovation in the development of cell & gene-based therapies targeting indications in, but not limited to, hematology/oncology, autoimmunity/chronic inflammatory diseases, and organ/tissue transplantation.

The Company's platforms were all initially discovered by scientists at the world-renowned Karolinska Institutet (KI) in Stockholm, Sweden. KI is globally recognized for its Nobel Assembly, which awards the Nobel Prize in Physiology or Medicine. For more information, please visit the Company's website at http://www.vycellix.com

Excerpt from:
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies - P&T...

Anatomy of a coronavirus disaster: how 2,700 people were let off the Ruby Princess cruise ship by mistake – The Guardian

On Thursday, the Ruby Princess cruise ship docked in Sydney harbour after an 11-day round trip to New Zealand.

Despite the ship previously logging 158 cases of illness on an earlier voyage, all 2,700 passengers on board were allowed to disembark at Sydneys Circular Quay and return to their homes in New South Wales and interstate.

So far, 133 people have been diagnosed with the disease after leaving the ship, and one person, a woman in her 70s, has died.

The NSW health minister, Brad Hazzard, admitted on Sunday that this was a mistake to let passengers disembark, and on Monday the prime minister, Scott Morrison, said the Australian defence force had been called in to help NSW Health track the passengers contacts.

How did a public health disaster like this happen?

The Ruby Princess arrived in Sydney on 8 March, having sailed from Port Chalmers in New Zealand on a previous tour.

According to the ships internal logs, 158 passengers on board were sick, with 13 registering high temperatures. Nine were tested upon arrival, according to the Australian newspaper. However, all passengers were allowed to disembark, including a Northern Territory couple who flew to Darwin, and later tested positive for Covid-19.

The ship was rated medium risk by NSW Health as a result of the 158 cases of illness.

Hours later, 2,700 new passengers boarded the ship in Sydney, and it set sail that night for another return trip to New Zealand.

According to ship tracker Marine Traffic, the Ruby Princess docked in Port Chalmers on Thursday 12 March, Wellington on Saturday 14 March and Napier on Sunday 15 March.

Five people developed influenza-like illness by Wellington on 14 March, NSW Health revealed a week later on Friday 20 March. They tested negative for Covid-19 at that time, NSW Health said.

On Sunday 15 March, the Ruby Princess left Napier and set a course for Sydney 63% of the passengers were Australian residents, 20% were American residents and the remaining 17% were from other countries.

Elisa Mccafferty, a passenger on the ship, told Guardian Australia that people were told to fill in a form declaring if they had a cough or fever, but at no point did the Ruby Princess inform passengers that there were suspected cases of coronavirus on board.

The Ruby Princess arrived in Sydney harbour. All of its 2,700 passengers were allowed to disembark at Circular Quay, with many heading immediately to domestic flights.

Despite being deemed medium risk a week earlier, the ship was deemed low risk that day because it had only travelled between New Zealand and Australia.

One passenger was unwell and taken directly from the ship to hospital, two presented to Sydney hospitals for testing after disembarking, and one was a crew member who was placed into isolation on the ship.

All four would later test positive for Covid-19, but the results of these tests would not be disclosed until Friday. The woman who was taken directly to hospital died on Tuesday morning.

Passenger Bill Beerens would later tell the ABC that he had a cough when he left the ship on Thursday, but was allowed to go home without testing. He went to a hospital that night and his test came back positive on Saturday.

He said other passengers near him also had coughs and sore throats.

Mccafferty said: At no point was anybody checked. As we were disembarking, they basically just scanned us off in groups. And we were let go. We didnt see any temperature scanning, nobody was pulled aside that we could see.

All passengers were told they would need to self-isolate at home or in a hotel for 14 days.

NSW Health announced that four passengers from the ship had tested positive, but all had disembarked and had already started journeying home, including interstate.

The health department said they began calling passengers, emailing and texting to inform them of the confirmed cases, and remind them to self-isolate and monitor for symptoms.

A spokesman for Princess Cruises told Guardian Australia that our onboard medical team was rigorous in its treatment of some guests who reported flu-like symptoms, and these guests were isolated.

The ship reported these cases to NSW Health, which in turn requested swabs to be provided following the ships arrival in Sydney, some of which subsequently tested positive for Covid-19.

NSW Health did not respond in time for publication about what assessments they conducted on passengers, and whether they knew if any passengers had symptoms of Covid-19.

On Tuesday 24, the department said in a public statement that no cases of Covid-19 had been identified by doctors on board before docking.

Hazzard admitted that it was a mistake to allow the 2,700 passengers to disembark on Thursday without testing.

If I had my opportunity to have my two bobs worth, with the benefit of what we now know about those people, Id have said yeah, maybe we should hold them on the ship, he told reporters.

The number of confirmed cases from the Ruby Princess rose to 26 in total 18 in NSW and eight interstate.

The number of confirmed cases from the ship rose to 48 in total 27 in NSW, and 21 interstate.

Morrison told parliament that NSW Health was responsible for allowing the passengers to disembark, and that the Australian Defence Force had been called in to help the department trace the contacts of the infected passengers.

The vessel was placed under the control of the NSW authorities including NSW Health and the NSW port authority, he told parliament. NSW Health has stated it undertook a full assessment of the Ruby Princess and allowed passengers to disembark.

Yesterday the ADF provided assistance to the NSW health department to provide contract tracing support [and] contact tracing activities relating to passengers from this vessel.

In a statement, the defence minister, Linda Reynolds, said ADF contact tracing support teams were being established in all states and territories.

The number of confirmed cases from the ship rose to 133 in total 107 in NSW, and 26 interstate.

A woman in her 70s, who was among the first four who tested positive, died in a Sydney hospital.

Original post:
Anatomy of a coronavirus disaster: how 2,700 people were let off the Ruby Princess cruise ship by mistake - The Guardian

SXSW 2020 Interview: Maria Finitzo on Identifying the Anatomy of Gender Inequality in The Dilemma of Desire – The Moveable Fest

At the start of making The Dilemma of Desire, Maria Finitzo and her producers has convened a meeting of the minds in Chicago, bringing together dozens of women from all walks of life to openly talk about what had long been a societal taboo their clitoris. The filmmaker had already been filming with Sophia Wallace, a multidisciplinary artist who had been trailblazing in fostering this conversation at large with her project Cliteracy, providing basic knowledge on female genitalia where sex ed had long failed, but when it took until 1998 for scientists even to be able to present a full structure of the clit since no proper study had been done before, Finitzo had to wonder whether the subject was still so obscure even amongst women that it might not be meaningful to address with a full feature film.

At one point, one of the women in the room said, I have hungered for this conversation. We never talk about this, recalls Finitzo. And it was quite wonderful because it validated my hunch that this was a film that would resonate with a wide audience.

In The Dilemma of Desire, Finitzo channels the energy of that conversation into a brisk, entertaining and edifying cultural history of the clitoris, making the convincing case that its absence in the public discourse, woefully underrepresented, if at all, in scientific research studies in relation to its male counterpart and largely made to feel as if its too private to talk about, has stymied the progress towards achieving full equality for women. Although the joke has always been that men cant find the clitoris, the punchline has been particularly cruel to women as Finitzo illustrates when in the opening moments of her film, Dr. Stacey Dutton, an assistant professor of biology at Agnes Scott College, has trouble locating it as she flips through the pages of Grays Anatomy, lamenting Its almost like they wiped womanhood out of the text.

Finitzo puts a face to how damaging this slight has been to society as a whole, following the work of Dr. Dutton; Dr. Lisa Diamond, a professor of psychology and gender studies at the University of Utah, Ti Chang, the co-founder of the female-driven sex toy manufacturer Crave, and Wallace, whose efforts can seem provocative merely when presenting basic facts, but widens her scope to include a collection of young women for whom more knowledge about sex at an early age wouldve changed their lives radically. The Dilemma of Desire introduces audiences to Coriama, Jasmine, Becca, Unmia and Sunny, all of whom can be seen speaking confidently to the camera now about their experiences, but describe how undermined theyve been throughout the years by being misinformed or outright misled about how their bodies work and the ripple effect that uncertainty has had on attaining personal and career goals.

The Dilemma of Desire can be seen bringing light to how knowledge is power in any number of ways, with effervescent subjects competing with neon-lit signs projecting Wallaces 100 Natural Laws throughout for what shines brightest, and Finitzo is able to acknowledge the awkwardness around the subject with good humor while never diminishing its importance. Although the films premiere was postponed when its intended bow at SXSW was cancelled as a result of the coronavirus, The Dilemma of Desire just cant be denied and in that spirit, Finitzo and I spoke about how she was inspired to make the film, bringing abstract concepts about patriarchal society and female empowerment into focus and why the subject seems more relevant than ever.

How did this come about?

It came from a lot of different places. I have two kids and one of them is a daughter and I remember when she was in high school, being appalled at the dangerous landscape she was navigating. I wasnt somebody that thought, Oh, my daughter has to wait until she gets married to have sex or any of that Im pretty pragmatic about that, but I was stumped by the fact that we tell girls and women that they can go out and hook up when in fact they really cant because the patriarchal system that punishes them for behaving how men are still behaving is still in place. And I remember reading a book in 2012 called The Science of Female Sexual Desire, What Do Women Want, written by a really great journalist Daniel Bergner. He had gone all over the country interviewing scientists who were studying female desire with women as subjects, which in itself was unusual, and at the end of the book, the scientists all said, Women have as robust a sex drive as men. Theyre simply told lies about it to reinforce patriarchal culture.

That really struck me as a starting point for a film about all the things that get in the way of women having agency over their desire and how that looks in their own life. I found Sophia Wallace because her work Cliteracy Under Natural Laws just blew me away because it was all so true and it was very eye-opening. I remember thinking that she was the woke person I had ever met and she remains the most woke person I ever met so we initially started filming with [her], Stacey Dutton, and Lisa Diamond, three of the experts, and Gordon Quinn, whos the creative director of Kartemquin Films, said to me, you need to find women who are just everyday women, who are not scientists or artists who are really ensconced in this topic because these women easily discuss sex. You need to find everyday women to see how what theyre studying resonates in their everyday life.

You really notice the racial and cultural diversity in the group that you find. Were you looking for certain experiences to follow?

What youre looking for when you go to put everyday people in your film is people for whom the experience of being in the film will be one they enjoy, and I believe that if I as a filmmaker set up the right environment, then everyone has a story and if Im a good filmmaker, everyones story will be powerful. And I didnt want this to just be a film about white, heterosexual, middle class women who have bad sex. I wanted it to really try as much as you can in one film to really include a wide range of voices, so thats what I went looking for and it worked out really well. [For instance] Coriama [a self-described queer African-American pleasure priestess], I went out to a number of people and said, Give me the names of some women that work in this space and bringing her into the film was a wonderful experience, for both the film and also for me in getting to know her and the work that she does in communities of color and the LGBTQ community, so it was important to me to have a wide range of voices.

One of the things that was also really helpful was to have Sophia Wallaces work, The 100 Natural Laws as a thematic ladder upon which I could pull together all of these different scenes. Because a lot of Sophias work is text, I wanted that text to come alive because its a film and it was really exciting to see how the laws are grounded in the real experience of women. Thats why I think they work so well throughout the film, and it was really fun working with the editors and some of the designers to say Okay, if the law emotionally punctuates the end of this scene, how does it do that? Its always an emotional punctuation, so it either has to reinforce something very serious or give you a reason to smile and laugh, like [the law] Can you draw a clitoris? And [the women in the film are] all laughing and it makes people [in the audience] laugh. So I really loved bringing that element into the film.

One of the difficult balancing acts of the film seems to be making this fun but not trivial, which you get across as early as the first scene of the film. Was that a challenge?

It was very hard because this wasnt a film that was like a typical narrative film, [where like] a scrappy underdog sports team makes it to the playoffs and you follow that story and they have the ups and the downs and then they finally either win or learn a bigger, important life lesson. Thats an easy narrative to follow and this film is an essay about female desire and its relationship to womens equality. Still, I think humor is really important in a movie, so some of the scenes have some humor in it, but theyre also dealing with really fundamental issues to personhood and citizenship, so I didnt want to trivialize that. So much of what happens [in popular culture representation] around female desire and pleasure is embarrassment, so people giggle or they laugh and I really didnt want that to be the experience that people had.

We start off telling you this is what the clitoris looks like and by the middle of the film, Sophia Wallace tells you its a symbol, a metaphor for inclusion, that all bodies are entitled to the pleasure theyre capable of and it belongs to everyone, and then it becomes a symbol for liberation, so thats the arc that the clitoris has to travel and I wanted that sense of empowerment, so while I want you to enjoy my film, I dont want you to leave the film bummed out because we deal with some very serious issues. I wanted you to come away with a sense of joy and a sense of potential for what our world might look like if all of us were entitled to live our lives within whatever capability we could. This isnt really a film about the clitoris, its about power and how power is easily taken when the lie is replaced with the truth, so when you deny women the knowledge of their bodies, youre cutting them off from a vibrant source of power in their lives.

You include some brief snippets of footage from the Brett Kavanaugh Supreme Court confirmation hearings was it interesting to be putting this together at a time when the inequality between men and women was made so clear?

Yeah, I started the film in 2016 before Trump was elected, and while we were all walking around a little worried, none of us couldve imagined what would happen. After 2016, it became how can you make this film during this time without acknowledging what is going on I wanted to do that, but I also did not want to make it a film about Donald Trump. So we had it in there at various times in different ways and then everybody said, No, take it out, take it out, and when it is finally mentioned [in the film now], its only enough for you to understand the context of the times.

What became clear to me as a filmmaker is how much more urgent the film seemed. I grew up in the 60s and 70s during womens liberation and I also grew up before Roe V. Wade and who wouldve thought we would now at this point be at a time in our lives where all of the reproductive rights that women had gained are now being taken away? To me that felt more and more urgent that we had gone backwards in time. Its not enough to say to young women, sure, you can sleep with whoever you want. Thats not really empowering. Thats just setting them up to get clobbered. If we really want to change the world, we have to find a way to dismantle a patriarchal system that is meant to be violent, and as Coriama says towards the end of the film, the only way to get out of it is to get rid of the fucking system.

The films premiere, scheduled to be at SXSW, has been put on hold because of the coronavirus, but when youve worked on this project for so long, whats it like to get to the finish line?

It felt great getting to the finish line because Ive had this film in my head visually for about six years, so finally when it all comes together and you work with a team of really talented people the composer and the editors and all the people who do your color correcting, its beautiful to finally see it. What Im missing right now is the experience of showing the film with an audience live because thats also a whole other incredible experience. It just changes everything, so Im really, really hoping to at some point in the future to be able to share this film with an audience.

The Dilemma of Desire does not yet have U.S. distribution. A schedule of future screenings is here.

Related

Link:
SXSW 2020 Interview: Maria Finitzo on Identifying the Anatomy of Gender Inequality in The Dilemma of Desire - The Moveable Fest

15 Polarizing TV Character Exits From Grey’s Anatomy, Buffy and More – Yahoo Entertainment

Saying goodbye to a beloved TV character is always tough, but it becomes even harder when something about their departure feels off.

As the debate surrounding Alexs exit from Greys Anatomy rages on 48 percent of TVLine readers still hate that Karev randomly reunited with secret-mom Izzie, while 25 percent love it and 27 percent admit to being somewhere in the middle we thought wed look back at some other polarizing TV departures on which we also admit to being somewhere in the middle.

More from TVLine

Quick disclaimer: This is more about the manner in which a key characters story was wrapped up, not the mere fact that an actor left a long-running show. For example, Nina Dobrevs departure from The Vampire Diaries after six seasons certainly sent shockwaves through the CW dramas fandom, but her characters exit storyline Elena was placed under a sleeping curse, keeping her somewhat in the picture was largely well-received by fans. In other words, not polarizing.

No, were talking about those truly WTF character departures that either had you screaming at your TV in disgust or desperately Googling in confusion. From unnecessary deaths on shows like Veronica Mars and Buffy the Vampire Slayer to unceremonious exits on shows like Lizzie McGuireand Law & Order: SVU, weve assembled 15 of TVs messiest conclusions.

And heres another disclaimer: Because were discussing major exits from more than a dozen TV shows, it should go without saying that this gallery is a spoiler minefield. Youve been warned.

Browse our gallery of some of TVs most polarizing exits you can click here for direct access thendrop a comment with your thoughts below. Which befuddling character departures would you add to our list?

Launch Gallery: TV's Most Polarizing Exits

Best of TVLine

Sign up for TVLine's Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.

View original post here:
15 Polarizing TV Character Exits From Grey's Anatomy, Buffy and More - Yahoo Entertainment

Grey’s Anatomy Spoilers: Will the Truth Come Out? – TV Fanatic

The doctors are away and ready to play.

That is what the promo for Grey's Anatomy Season 16 Episode 19 teases, and we are so ready for it.

ABC also dropped a press release to give fans a taste of what's to come.

"Love of My Life" - Richard preps to present his PATH pen at the LA Surgical Innovation Conference but becomes distracted by his issues with Catherine.

Maggie and Teddy run into people from their past at the same conference, while Hayes relives moments from when he met his late wife, on an all-new episode of "Grey's Anatomy," THURSDAY, MARCH 26 (9:00-10:01 p.m. EDT), on ABC. (TV-14, DS)

Episodes can also be viewed the next day on demand and on Hulu. "Grey's Anatomy" stars Ellen Pompeo as Meredith Grey, Chandra Wilson as Miranda Bailey, James Pickens Jr. as Richard Webber, Kevin McKidd as Owen Hunt, Jesse Williams as Jackson Avery, Caterina Scorsone as Amelia Shepherd, Camilla Luddington as Jo Wilson, Kelly McCreary as Maggie Pierce, Kim Raver as Teddy Altman, Giacomo Gianniotti as Andrew DeLuca, Greg Germann as Tom Koracick, Chris Carmack as Atticus "Link" Lincoln and Jake Borelli as Levi Schmitt.

Guest starring is Debbie Allen as Catherine Fox and Richard Flood as Cormac Hayes.

"Love of My Life"was written by Kiley Donovan and Andy Reaser, and directed by Alison Liddi-Brown.

It sounds like another bottle episode is on the horizon, and there's nothing wrong with that, so long as it benefits the arcs of the respective characters.

Richard and Catherine's issues taking center stage should allow them to finally move on with their lives. There's a slim chance they could get back together, but it seems the love between them has fizzled out.

Maggie and Teddy being out of town and meeting people from their past should present some fun moments for both characters.

Maggie recently broke up with Jackson, and based on the official trailer for the episode, she will find someone new to cosy up to.

As for Teddy, she's been cheating on Owen with Tom and feels terrible about it. Something is bound to happen on the trip that will make her come clean to Owen about her infidelity.

Whether that will result in the implosion of their relationship, we don't know, but we need some movement on that front.

Hayes opening up about his past could be exciting.

We've heard him talk about his wife to Meredith, but whether he will be opening up to her or another character is not something that has been confirmed.

That being said, it does seem like Meredith is not on the trip.

The producers really need to make Richard Flood are more permanent cast member because Hayes one of the best on the show. There is a lot of potential for his character.

Have a look at the full trailer for "Love of My Life," and hit the comments with your thoughts on it.

Grey's Anatomy airs Thursdays at 9/8c on ABC.

Remember you can watch Grey's Anatomy online right here via TV Fanatic.

Edit Delete

Paul Dailly is the Associate Editor for TV Fanatic. Follow him on Twitter.

Read more:
Grey's Anatomy Spoilers: Will the Truth Come Out? - TV Fanatic

Friends? The Office? Grey’s Anatomy? Watch them all on MENA’S STARZPLAY! – Startup MGZN

The entertainment fiesta never stops on STARZPLAY, the leading subscription video on demand (SVOD) service in the MENA region, which continues to provide its million-plus subscribers with premium content. With people spending more time at home now, this is the perfect opportunity to binge-watch your favorite shows. From full box sets of the best shows to the latest must-watch Hollywood blockbusters as well as continuing hit titles, there is something for everyone.

Watch the cult classic sitcom,The Big Bang Theory, which remains a top choice for comedy fans, and especially popular among STARZPLAY subscribers, who had the chance of watching the series finale on the platform at the same time it aired in the US last May. So, it may be time for fans to re-visit their favorite scientist pals (and Penny!) and enjoy all 12 seasons of the Golden Globe and Emmy awards winning series, only on STARZPLAY.

STARZPLAY is also home to the much-loved American sitcomThe Office, the mockumentary on a group of typical office workers where the workday consists of ego clashes, inappropriate behavior, and boredom. Fans can watch all the nine-seasons of the hilarious documentary-style TV series that tells stories about contemporary work culture in the most hysterical way.

Fans of the epic historical dramaVikings can watch every new episode of the sixth and final season of the epic action-adventure, that has turned into a worldwide phenomenon,exclusively on STARZPLAY. And for those who are yet to delve into the shows fascinating world, all previous 5 seasons are currently available on the platform.

While the world celebrated the 25thanniversary of the launch ofFriendslast year, the show remains one of the most beloved and popular sitcoms in TV history, STARZPLAY subscribers can binge-watch all ten seasons of the classic comedy through the platform anytime, anywhere and from any device, and share this joyful experience with their own friends.

Fans of the American television medical dramaGreys Anatomycan watch every new episode of the fifteenth season starting March 28 on STARZPLAY. Watch how surgical interns and their supervisors embark on a medical journey where they become part of heart-wrenching stories and make life-changing decisions in order to become the finest doctors.

Available in 20 countries across the Middle East, North Africa and Pakistan, with more than 10,000 hours of content including premium movies, exclusive and Arabic series, STARZPLAY has also secured its place as the number one player in the MENA region.

As shared in a press release.

Go here to see the original:
Friends? The Office? Grey's Anatomy? Watch them all on MENA'S STARZPLAY! - Startup MGZN